Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity

被引:11
作者
Kim, Nick [1 ]
Meyers, Kenneth M. [1 ]
Mendez-Andino, Jose L. [1 ]
Warshakoon, Namal C. [1 ]
Ji, Wei [1 ]
Wos, John A. [1 ]
Colson, Annyodile [1 ]
Mitchell, M. Chrissy [1 ]
Davis, Jan R. [1 ]
Pinney, Beth B. [1 ]
Reizes, Ofer [1 ]
Hu, X. Eric [1 ]
机构
[1] Procter & Gamble Pharmaceut, Mason, OH 45040 USA
关键词
MCH-R1; antagonist; obesity; aminopiperidine; aminopyrrolidine;
D O I
10.1016/j.bmcl.2006.07.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A substituted 4-aminopiperidine was identified as showing activity in an MCH assay from an HTS effort. Subsequent structural modification of the scaffold led to the identification of a number of active MCH antagonists. 3,5-Dimethoxy-N-(1-(naphthalen-2-ylmethyl)piperidin-4-yl)benzamide (5c) was among those with the highest binding affinity to the MCH receptor (K-i = 27 nM), when variations were made at benzoyl and naphthylmethyl substitution sites from the initial HTS hit. Further optimization via piperidine ring contraction resulted in enhanced MCH activity in a 3-aminopyrrolidine series, where (R)-3,5-dimethoxy-N-(1-(naphthalen-2-ylmethyl)-pyrrolidin-3-yl)benzamide (10i) was found to be an excellent MCH antagonist (K-i = 7 nM). (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5445 / 5450
页数:6
相关论文
共 19 条
[1]   THE MELANIN-CONCENTRATING HORMONE SYSTEM OF THE RAT-BRAIN - AN IMMUNIZATION AND HYBRIDIZATION HISTOCHEMICAL CHARACTERIZATION [J].
BITTENCOURT, JC ;
PRESSE, F ;
ARIAS, C ;
PETO, C ;
VAUGHAN, J ;
NAHON, JL ;
VALE, W ;
SAWCHENKO, PE .
JOURNAL OF COMPARATIVE NEUROLOGY, 1992, 319 (02) :218-245
[2]   A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties [J].
Dyck, Brian ;
Markison, Stacy ;
Zhao, Liren ;
Tamiya, Junko ;
Grey, Jonathan ;
Rowbottom, Martin W. ;
Zhang, Mingzhu ;
Vickers, Troy ;
Sorensen, Katie ;
Norton, Christi ;
Wen, Jenny ;
Heise, Christopher E. ;
Saunders, John ;
Conlon, Paul ;
Madan, Ajay ;
Schwarz, David ;
Goodfellow, Val S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) :3753-3756
[3]   The melanocortin system and its role in obesity and cachexia [J].
Goodfellow, VS ;
Saunders, J .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (08) :855-883
[4]   Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists [J].
Grey, J ;
Dyck, B ;
Rowbottom, MW ;
Tamiya, J ;
Vickers, TD ;
Zhang, MZ ;
Zhao, LR ;
Heise, CE ;
Schwarz, D ;
Saunders, J ;
Goodfellow, VS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) :999-1004
[5]   Obesity drug pipeline not so fat [J].
Gura, T .
SCIENCE, 2003, 299 (5608) :849-852
[6]   Obesity and the environment: Where do we go from here? [J].
Hill, JO ;
Wyatt, HR ;
Reed, GW ;
Peters, JC .
SCIENCE, 2003, 299 (5608) :853-855
[7]   1-(4-amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists [J].
Huang, CQ ;
Baker, T ;
Schwarz, D ;
Fan, J ;
Heise, CE ;
Zhang, MZ ;
Goodfellow, VS ;
Markison, S ;
Gogas, KR ;
Chen, TK ;
Wang, XC ;
Zhu, YF .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (16) :3701-3706
[8]  
KAKO H, Patent No. 2005325031
[9]  
KAKU H, Patent No. 2004046110
[10]   Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for obesity the treatment of obesity [J].
Kowalski, TJ ;
McBriar, MD .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) :1113-1122